Last reviewed · How we verify
Carbomer
At a glance
| Generic name | Carbomer |
|---|---|
| Also known as | Vidisic® Gel |
| Sponsor | China Medical University Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Skin Barrier Function and Inflammation in Aging: The BIA Study (PHASE4)
- Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy (NA)
- A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases (PHASE2)
- Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel (PHASE1)
- Topical Acetaminophen for Itch Relief: a Proof of Concept Study in Healthy Subjects (PHASE1, PHASE2)
- Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease (NA)
- Efficacy of Coconut Gel Compared to Corticosteroid Gel in the Management of Oral Lichen Planus (PHASE4)
- Effect of Local Use of Non-steroidal Anti-inflammatory Agent (Diclofenac Sodium) With and Without Hyaluronidase on Post-surgical Pain and Swelling (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |